Duchenne muscular dystrophy trials in Serbia

2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Serbia
  Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

  Where

  Belgrade

  Age

  9 years to 17 years

  People

  138 worldwide

  Run by

  Italfarmaco

  See details and how to joinNCT05933057 · EU 2023-503521-19-00
• Phase 2/3Enrolling by invitation
  Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

  Where

  Belgrade

  Age

  7 years and over

  People

  206 worldwide

  Run by

  Italfarmaco

  See details and how to joinNCT03373968